HCV-RNA levels at 3 points were available in 34 patients; pretreatment level, highest levels from initiation of treatment to 1 month after completing treatment, and from 1 to 6 months after treatment. HCV-RNA significantly increased during immunochemotherapy (P = .006) and then decreased after treatment (P = .003).